investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Illuminating the Druggable Genome

Tudor Oprea

7 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Larry A Sklar

University of New Mexico

Albuquerque, United States

Stephen C Schurer

University of Miami

Coral Gables, United States

Soren Brunak

Novo Nordisk (Denmark)

Copenhagen, Denmark

Tudor Oprea

University of New Mexico

Albuquerque, United States

Related projects

Alan Fersht

Structural biology of the tumour suppressor p53 and its complexes

All cancers but non-melanoma skin cancer

Allan Weissman

Enzymes and Substrates of the Ubiquitin Conjugating System

All cancers but non-melanoma skin cancer

Stephen Hughes

Integrase

All cancers but non-melanoma skin cancer

Arash Hatefi

Bioengineering a Safe and Efficient Vector Technology for Stem Cell Transfection

All cancers but non-melanoma skin cancer

Joseph Barchi

A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead

All cancers but non-melanoma skin cancer

Karsten Melcher

Structural interrogation of allosteric AMPK regulation

All cancers but non-melanoma skin cancer

Masanobu Komatsu

Normalization of Tumor Vasculature by R-Ras

All cancers but non-melanoma skin cancer

David J. Kwiatkowski

Molecular Pathogenesis of the Hamartoma Syndromes

All cancers but non-melanoma skin cancer

Pathology

Eileen P. White

Identification of Metabolic Vulnerabilities of Ras-Driven Cancer Cells

All cancers but non-melanoma skin cancer